ARCHIVES

Techniclone Wins Patent For Tumor Necrosis Therapy.

This article is from The Cancer Letter archive.

Vol. 26 No. 08 | February 25, 2000

Download PDF Visit The Full Archive

Related Articles

No Benefit For Cetuximab In Early-Stage Colon Cancer

December 25, 2009

Rall Says NTP Must Have New Positions To Spend Extra $23 Million On Testing More Chemicals

September 7, 1979

NCI’s Supercomputer Undergoing Testing

April 11, 1986

Funding opportunities listed.

February 20, 2004

Data Presented At Scientific Meetings Can Have Impact On Patient Treatment

March 31, 2006

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014